The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
De-escalated neoadjuvant taxane plus trastuzumab and pertuzumab with or without carboplatin in HER2-positive early breast cancer (neoCARHP): A multicentre, open-label, randomised, phase 3 trial.
 
Hong-Fei Gao
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Zhiyong Wu
No Relationships to Disclose
 
Jie Dong
No Relationships to Disclose
 
Yin Cao
No Relationships to Disclose
 
Yanxia Zhao
No Relationships to Disclose
 
Qian-Jun Chen
No Relationships to Disclose
 
Shihui Ma
No Relationships to Disclose
 
Jie Ouyang
No Relationships to Disclose
 
Jin-Hui Ye
No Relationships to Disclose
 
Huawei Yang
No Relationships to Disclose
 
Yuanqi Zhang
No Relationships to Disclose
 
Yongcheng Zhang
No Relationships to Disclose
 
Gangling Zhang
No Relationships to Disclose
 
Yingyi Lin
No Relationships to Disclose
 
Ying Lin
No Relationships to Disclose
 
Guo-Lin Ye
No Relationships to Disclose
 
Zefei Jiang
No Relationships to Disclose
 
Kun Wang
No Relationships to Disclose